12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Eliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday’s pre-market session. The market value…
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Fresh Tracks Therapeutics (NASDAQ:FRTX) stock rose 35.2% to $0.92 during Friday’s pre-market session. The company’s market cap…
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Gainers
BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital Market.
What’s Happening With Eliem Therapeutics Shares Today?
Eliem Therapeutics Inc (NASDAQ: ELYM) shares are trading higher after the company completed a review of its business, including the status of its programs,
HC Wainwright & Co. Reiterates Neutral on Eliem Therapeutics, Maintains $6 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Eliem Therapeutics (NASDAQ:ELYM) with a Neutral and maintains $6 price target.
Eliem Therapeutics Q4 EPS $(0.29) Beats $(0.38) Estimate
Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.38) by 23.68 percent. This is a 27.5 percent increase over losses of $(0.40) per share from
Eliem Therapeutics CEO Robert Azelby, COO And CFO Erin Lavelle Resigned Effective February 13 As It Decides To Cut Workforce By 55%
On February 13, 2023, Eliem entered into a letter agreement with three of its executive officers – President, Chief Executive Officer and Director Robert Azelby, Executive Vice President, Chief Operating
Eliem Pauses Development On Depression Drug, Lays Off 55% Workforce
Eliem Therapeutics Inc (NASDAQ:ELYM) announced reprioritizing its pipeline to focus on its high potential preclinical Kv7.2/3 program (Kv7 Program) and the…
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.